{ "labelLang" : "hun", "responseDate" : "2024-03-29 08:22", "content" : { "otype" : "BookChapter", "mtid" : 23451185, "status" : "ADMIN_APPROVED", "published" : true, "unhandledTickets" : 0, "oldTimestamp" : "2018-09-13T11:57:09.000+0000", "deleted" : false, "oldId" : 13451185, "lastRefresh" : "2023-12-13T17:38:54.844+0000", "lastModified" : "2018-09-13T11:57:09.000+0000", "created" : "2013-11-14T19:12:31.000+0000", "creator" : { "otype" : "Author", "mtid" : 10000041, "link" : "/api/author/10000041", "label" : "Szabó András (Gyermekgyógyászat)", "familyName" : "Szabó", "givenName" : "András", "published" : true, "oldId" : 10000041, "snippet" : true }, "duplumSearchResult" : { "id" : 4821709, "creationDate" : "2024-03-27T12:02:18.206+0000", "startDate" : "2024-03-27T12:02:18.343+0000", "creator" : { "otype" : "Admin", "mtid" : 10045296, "link" : "/api/admin/10045296", "label" : "Cseh Éva (SE_AOK_Adm5_1GyermekgyCsehÉva, admin)", "familyName" : "Cseh", "givenName" : "Éva", "published" : true, "oldId" : 10045296, "snippet" : true } }, "duplumRole" : "SUSPECT", "lastDuplumSearch" : "2024-03-27T12:02:18.343+0000", "adminApproved" : "2013-11-14T19:43:02.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10019974, "link" : "/api/admin/10019974", "label" : "Szűts Ferencné (SE_AOK_2Gyerek_Admin5_SzFné, admin)", "familyName" : "Szűts", "givenName" : "Ferencné", "published" : true, "oldId" : 10019974, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Könyvfejezet (Könyvrészlet)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Dusso, AS", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 30721057, "link" : "/api/authorship/30721057", "label" : "Dusso, AS", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Dusso", "givenName" : "AS", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 47988839, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 30721058, "link" : "/api/authorship/30721058", "label" : "Slatopolsky, E", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Slatopolsky", "givenName" : "E", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 47988838, "snippet" : true } ], "title" : "Vitamin D and renal disease", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6857997, "link" : "/api/publicationidentifier/6857997", "label" : "DOI: 10.1016/B978-0-12-381978-9.10070-8", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "NO", "idValue" : "10.1016/B978-0-12-381978-9.10070-8", "realUrl" : "https://doi.org/10.1016/B978-0-12-381978-9.10070-8", "published" : false, "oldId" : 4410499, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 6857996, "link" : "/api/publicationidentifier/6857996", "label" : "Scopus: 84865160043", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "NO", "idValue" : "84865160043", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84865160043", "published" : false, "oldId" : 4410498, "snippet" : true } ], "firstPage" : "1325", "lastPage" : "1357", "firstPageOrInternalIdForSort" : "1325", "pageLength" : 33, "publishedYear" : 2011, "digital" : null, "printed" : null, "sourceYear" : 2013, "packet" : "(Szűts Ferencné (SE_AOK_Adm5_2Gyerek_SzF...); 2013.11.14. 20:10:56)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-12-13", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 3, "citedCount" : 3, "referenceList" : "Moe, S.M., Drueke, T., Improving global outcomes in mineral and bone disorders (2008) Clin. J. Am. Soc. Nephrol., 3 (SUPPL. 3), pp. S127-S130; \n\nBrown, A.J., Dusso, A., Slatopolsky, E., Vitamin D (1999) Am. J. Physiol., 277, pp. F157-F175; \n\nDusso, A.S., Brown, A.J., Slatopolsky, E., Vitamin D (2005) Am. J. Physiol. Renal. Physiol., 289, pp. F8-28; \n\nBarthel, T.K., Mathern, D.R., Whitfield, G.K., Haussler, C.A., Hsieh, J.C., Hopper, H., 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism (2007) J. Steroid Biochem. Mol. Biol., 103, pp. 381-388; \n\nKolek, O.I., Hines, E.R., Jones, M.D., LeSueur, L.K., Lipko, M.A., Kiela, P.R., 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport (2005) Am. J. Physiol. Gastrointest. Liver Physiol., 289, pp. G1036-G1042; \n\nSchiavi, S.C., Kumar, R., The phosphatonin pathway: new insights in phosphate homeostasis (2004) Kidney Int., 65, pp. 1-14; \n\nShimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis (2004) J. Bone Miner. Res., 19, pp. 429-435; \n\nKrajisnik, T., Bjorklund, P., Marsell, R., Ljunggren, O., Akerstrom, G., Jonsson, K.B., Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells (2007) J. Endocrinol., 195, pp. 125-131; \n\nSlatopolsky, E., Brown, A., Dusso, A., Pathogenesis of secondary hyperparathyroidism (1999) Kidney Int. Suppl., 73, pp. S14-S19; \n\nBellorin-Font, E., Humpierres, J., Weisinger, J.R., Milanes, C.L., Sylva, V., Paz-Martinez, V., Effect of metabolic acidosis on the PTH receptor-adenylate cyclase system of canine kidney (1985) Am. J. Physiol., 249, pp. F566-F572; \n\nTeng, M., Wolf, M., Ofsthun, M.N., Lazarus, J.M., Hernan, M.A., Camargo, C.A., Activated injectable vitamin D and hemodialysis survival: a historical cohort study (2005) J. Am. Soc. Nephrol., 16, pp. 1115-1125; \n\nAl-Badr, W., Martin, K.J., Vitamin D and kidney disease (2008) Clin. J. Am. Soc. Nephrol., 3, pp. 1555-1560; \n\nMelamed, M.L., Astor, B., Michos, E.D., Hostetter, T.H., Powe, N.R., Muntner, P., 25-Hydroxyvitamin D levels, race, and the progression of kidney disease (2009) J. Am. Soc. Nephrol., 20, pp. 2631-2639; \n\nHolick, M.F., Vitamin D deficiency (2007) N. Engl. J. Med., 357, pp. 266-281; \n\nde Boer, I.H., Ioannou, G.N., Kestenbaum, B., Brunzell, J.D., Weiss, N.S., 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) (2007) Am. J. Kidney Dis., 50, pp. 69-77; \n\nWolf, M., Shah, A., Gutierrez, O., Ankers, E., Monroy, M., Tamez, H., Vitamin D levels and early mortality among incident hemodialysis patients (2007) Kidney Int., 72, pp. 1004-1013; \n\nMelamed, M.L., Michos, E.D., Post, W., Astor, B., 25-Hydroxyvitamin D levels and the risk of mortality in the general population (2008) Arch. Intern. Med., 168, pp. 1629-1637; \n\nTownsend, K., Evans, K.N., Campbell, M.J., Colston, K.W., Adams, J.S., Hewison, M., Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment (2005) J. Steroid Biochem. Mol. Biol., 97, pp. 103-109; \n\nMartinez, I., Saracho, R., Montenegro, J., Llach, F., A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism (1996) Nephrol. Dial. Transplant., 11 (SUPPL. 3), pp. 22-28; \n\nMason, R.S., Lissner, D., Wilkinson, M., Posen, S., Vitamin D metabolites and their relationship to azotaemic osteodystrophy (1980) Clin. Endocrinol. (Oxf.), 13, pp. 375-385; \n\nChristiansen, C., Christensen, M.S., Melsen, F., Rodbro, P., DeLuca, H.F., Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D (1981) Clin. Nephrol., 15, pp. 18-22; \n\nJuttmann, J.R., Buurman, C.J., De Kam, E., Visser, T.J., Birkenhager, J.C., Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives (1981) Clin. Endocrinol. (Oxf.), 14, pp. 225-236; \n\nTessitore, N., Venturi, A., Adami, S., Roncari, C., Rugiu, C., Corgnati, A., Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure (1987) Miner. Electrolyte Metab., 13, pp. 38-44; \n\nWilson, L., Felsenfeld, A., Drezner, M.K., Llach, F., Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D (1985) Kidney Int., 27, pp. 565-573; \n\nUsatii, M., Rousseau, L., Demers, C., Petit, J.L., Brossard, J.H., Gascon-Barre, M., Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis (2007) Kidney Int., 72, pp. 1330-1335; \n\nHalloran, B.P., Schaefer, P., Lifschitz, M., Levens, M., Goldsmith, R.S., Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3 (1984) J. Clin. Endocrinol. Metab., 59, pp. 1063-1069; \n\nNykjaer, A., Dragun, D., Walther, D., Vorum, H., Jacobsen, C., Herz, J., An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 (1999) Cell, 96, pp. 507-515; \n\nTakemoto, F., Shinki, T., Yokoyama, K., Inokami, T., Hara, S., Yamada, A., Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats (2003) Kidney Int., 64, pp. 414-420; \n\nLiu, W., Yu, W.R., Carling, T., Juhlin, C., Rastad, J., Ridefelt, P., Regulation of gp330/megalin expression by vitamins A and D (1998) Eur. J. Clin. Invest., 28, pp. 100-107; \n\nAl-Aly, Z., Qazi, R.A., Gonzalez, E.A., Zeringue, A., Martin, K.J., Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD (2007) Am. J. Kidney Dis., 50, pp. 59-68; \n\nHaussler, M.R., Baylink, D.J., Hughes, M.R., Brumbaugh, P.F., Wergedal, J.E., Shen, F.H., The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels (1976) Clin. Endocrinol. (Oxf.), 5 (SUPPL.), pp. 151S-165S; \n\nGarabedian, M., Holick, M.F., Deluca, H.F., Boyle, I.T., Control of 25-hydroxycholecalciferol metabolism by parathyroid glands (1972) Proc. Natl. Acad. Sci. USA, 69, pp. 1673-1676; \n\nHenry, H.L., Norman, A.W., Vitamin D: metabolism and biological actions (1984) Annu. Rev. Nutr., 4, pp. 493-520; \n\nMurayama, A., Takeyama, K., Kitanaka, S., Kodera, Y., Hosoya, T., Kato, S., The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3 (1998) Biochem. Biophys. Res. Commun., 249, pp. 11-16; \n\nBrenza, H.L., Kimmel-Jehan, C., Jehan, F., Shinki, T., Wakino, S., Anazawa, H., Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 1387-1391; \n\nRitz, E., Seidel, A., Ramisch, H., Szabo, A., Bouillon, R., Attenuated rise of 1,25(OH)2 vitamin D3 in response to parathyroid hormone in patients with incipient renal failure (1991) Nephron, 57, pp. 314-318; \n\nBeck, N., Kim, H.P., Kim, K.S., Effect of metabolic acidosis on renal action of parathyroid hormone (1975) Am. J. Physiol., 228, pp. 1483-1488; \n\nShinki, T., Shimada, H., Wakino, S., Anazawa, H., Hayashi, M., Saruta, T., Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 12920-12925; \n\nPrince, R.L., Hutchison, B.G., Kent, J.C., Kent, G.N., Retallack, R.W., Calcitriol deficiency with retained synthetic reserve in chronic renal failure (1988) Kidney Int., 33, pp. 722-728; \n\nPortale, A.A., Halloran, B.P., Morris, R.C., Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men (1989) J. Clin. Invest., 83, pp. 1494-1499; \n\nZhang, M.Y., Wang, X., Wang, J.T., Compagnone, N.A., Mellon, S.H., Olson, J.L., Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule (2002) Endocrinology, 143, pp. 587-595; \n\nYoshida, T., Yoshida, N., Monkawa, T., Hayashi, M., Saruta, T., Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression (2001) Endocrinology, 142, pp. 1720-1726; \n\nGray, R.W., Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy (1981) Calcif. Tissue Int., 33, pp. 485-488; \n\nLucas, P.A., Brown, R.C., Woodhead, J.S., Coles, G.A., 1,25-Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction (1986) Clin. Nephrol., 25, pp. 7-10; \n\nLopez-Hilker, S., Dusso, A.S., Rapp, N.S., Martin, K.J., Slatopolsky, E., Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol (1990) Am. J. Physiol., 259, pp. F432-F437; \n\nTenenhouse, H.S., Martel, J., Gauthier, C., Zhang, M.Y., Portale, A.A., Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate (2001) Endocrinology, 142, pp. 1124-1129; \n\nPerwad, F., Azam, N., Zhang, M.Y., Yamashita, T., Tenenhouse, H.S., Portale, A.A., Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice (2005) Endocrinology, 146, pp. 5358-5364; \n\nHsu, C.H., Patel, S., Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity (1992) J. Am. Soc. Nephrol., 3, pp. 947-952; \n\nGafter, U., Kraut, J.A., Lee, D.B., Silis, V., Walling, M.W., Kurokawa, K., Effect of metabolic acidosis in intestinal absorption of calcium and phosphorus (1980) Am. J. Physiol., 239, pp. G480-G484; \n\nBushinsky, D.A., Favus, M.J., Schneider, A.B., Sen, P.K., Sherwood, L.M., Coe, F.L., Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet (1982) Am. J. Physiol., 243, pp. F570-F575; \n\nKraut, J.A., Gordon, E.M., Ransom, J.C., Horst, R., Slatopolsky, E., Coburn, J.W., Effect of chronic metabolic acidosis on vitamin D metabolism in humans (1983) Kidney Int., 24, pp. 644-648; \n\nBushinsky, D.A., Riera, G.S., Favus, M.J., Coe, F.L., Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis (1985) Am. J. Physiol., 249, pp. F361-F365; \n\nLangman, C.B., Bushinsky, D.A., Favus, M.J., Coe, F.L., Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis (1986) Am. J. Physiol., 251, pp. F911-F918; \n\nPortale, A.A., Booth, B.E., Halloran, B.P., Morris, R.C., Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency (1984) J. Clin. Invest., 73, pp. 1580-1589; \n\nSchiavi, S.C., Kumar, R., The phosphatonin pathway: new insights in phosphate homeostasis (2004) Kidney International, 65, pp. 1-14; \n\nShimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa (2004) Biochem. Biophys. Res. Comm., 314, pp. 409-414; \n\nHu, M.C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Shawkat Razzaque, M., Moe, O.W., Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule (2010) FASEB J., 24, pp. 3438-3450; \n\nTsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., Nabeshima, Y., Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system (2003) Mol. Endocrinol., 17, pp. 2393-2403; \n\nNakatani, T., Ohnishi, M., Razzaque, M.S., Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model (2009) FASEB J., 23, pp. 3702-3711; \n\nBerndt, T., Craig, T.A., Bowe, A.E., Vassiliadis, J., Reczek, D., Finnegan, R., Secreted frizzled-related protein 4 is potent tumor-derived phosphaturic agent (2003) J. Clin. Invest., 112, pp. 785-794; \n\nRowe, P.S.N., Kumagai, Y., Garrett, R., Blacher, R., Escobada, A., Mundy, G.R., CHO-cells expressing MEPE, PHEX and co-expressing MEPE/PHEX cause major changes in BMD, Pi and serum alkaline phosphatase in nude mice (2002) J. Bone Min. Res., 17, pp. S211; \n\nYoshida, T., Fujimori, T., Nabeshima, Y., Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene (2002) Endocrinology, 143, pp. 683-689; \n\nHenry, H.L., Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells (1979) J. Biol. Chem., 254, pp. 2722-2729; \n\nTrechsel, U., Bonjour, J.P., Fleisch, H., Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells (1979) J. Clin. Invest., 64, pp. 206-217; \n\nTakeyama, K., Kitanaka, S., Sato, T., Kobori, M., Yanagisawa, J., Kato, S., 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis (1997) Science, 277, pp. 1827-1830; \n\nSt.-Arnaud, R., Messerlian, S., Moir, J.M., Omdahl, J.L., Glorieux, F.H., The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus (1997) J. Bone Min. Res., 12, pp. 1552-1559; \n\nShinki, T., Shimada, H., Wakino, S., Anazawa, H., Hayashi, M., Saruta, T., Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 12920-12925; \n\nMonkawa, T., Yoshida, T., Wakino, S., Shinki, T., Anazawa, H., Deluca, H.F., Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylase (1997) Biochem. Biophys. Res. Comm., 239, pp. 527-533; \n\nBrenza, H.L., Kimmeljehan, C., Jehan, F., Shinki, T., Wakino, S., Anzawa, H., Parathyroid hormone activation of the 25-hydroxyvitamin D3 1α-hydroxylase gene promoter (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 1387-1391; \n\nHenry, H.L., Insulin permits parathyroid hormone stimulation of 1,25-dihydroxyvitamin D3 production in cultured kidney cells (1981) Endocrinology, 108, pp. 733-735; \n\nMaierhofer, W.J., Gray, R.W., Adams, N.D., Smith, G.A., Lemann, J., Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods (1981) J. Clin. Endocrinol. Metab., 53, pp. 472-475; \n\nHsu, C.H., Patel, S., Buchsbaum, B.L., Calcitriol metabolism in patients with chronic renal failure (1991) Am. J. Kidney Dis., 17, pp. 185-190; \n\nHsu, C.H., Patel, S., Young, E.W., Simpson, R.U., Production and degradation of calcitriol in renal failure rats (1987) Am. J. Physiol., 253, pp. F1015-F1019; \n\nDusso, A., Lopez-Hilker, S., Lewis-Finch, J., Grooms, P., Brown, A., Martin, K., Metabolic clearance rate and production rate of calcitriol in uremia (1989) Kidney Int., 35, pp. 860-864; \n\nDusso, A., Lopez-Hilker, S., Lewis-Finch, J., Grooms, P., Brown, A., Martin, K., Metabolic clearance rate and production rate of calcitriol in uremia (1989) Kidney Int., 35, pp. 860-864; \n\nKoyama, H., Inaba, M., Nishizawa, Y., Ishimura, E., Imanishi, Y., Hini, M., Potentiated 1,25(OH)2D3-induced 24-hydroxylase gene expression in uremic rat intestine (1994) Am. J. Physiol., 267, pp. F926-F930; \n\nJuttmann, J.R., Hagenouw-Taal, J.C., Lameyer, L.D., Ruis, A.M., Birkenhager, J.C., Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysis (1978) Calcif. Tissue Res., 26, pp. 119-126; \n\nLee, S.W., Russell, J., Avioli, L.V., 25-Hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis (1977) Science, 195, pp. 994-996; \n\nPascussi, J.M., Robert, A., Nguyen, M., Walrant-Debray, O., Garabedian, M., Martin, P., Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia (2005) J. Clin. Invest., 115, pp. 177-186; \n\nDusso, A., Lopez-Hilker, S., Rapp, N., Slatopolsky, E., Extra-renal production of calcitriol in chronic renal failure (1988) Kidney Int., 34, pp. 368-375; \n\nDusso, A.S., Finch, J., Brown, A., Ritter, C., Delmez, J., Schreiner, G., Extrarenal production of calcitriol in normal and uremic humans (1991) J. Clin. Endocrinol. Metab., 72, pp. 157-164; \n\nGallieni, M., Kamimura, S., Ahmed, A., Bravo, E., Delmez, J., Slatopolsky, E., Kinetics of monocyte 1 alpha-hydroxylase in renal failure (1995) Am. J. Physiol., 268, pp. F746-F753; \n\nDusso, A.S., Kamimura, S., Gallieni, M., Zhong, M., Negrea, L., Shapiro, S., Gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses (1997) J. Clin. Endocrinol. Metab., 82, pp. 2222-2232; \n\nKomaba, H., Goto, S., Fujii, H., Hamada, Y., Kobayashi, A., Shibuya, K., Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients (2010) Kidney Int., 77, pp. 232-238; \n\nGallieni, M., Kamimura, S., Ahmed, A., Bravo, E., Delmez, J., Slatopolsky, E., Kinetics of monocyte 1 alpha-hydroxylase in renal failure (1995) Am. J. Physiol., 268, pp. F746-F753; \n\nKohno, M., Takahashi, S., Oida, K., Suzuki, J., Tamai, T., Yamamoto, T., 1 alpha,25-Dihydroxyvitamin D3 induces very low density lipoprotein receptor mRNA expression in HL-60 cells in association with monocytic differentiation (1997) Atherosclerosis, 133, pp. 45-49; \n\nJouni, Z.E., Winzerling, J.J., McNamara, D.J., 1,25-Dihydroxyvitamin D3-induced HL-60 macrophages: regulation of cholesterol and LDL metabolism (1995) Atherosclerosis, 117, pp. 125-138; \n\nSegersten, U., Correa, P., Hewison, M., Hellman, P., Dralle, H., Carling, T., 25-Hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands (2002) J. Clin. Endocrinol. Metab., 87, pp. 2967-2972; \n\nRitter, C.S., Armbrecht, H.J., Slatopolsky, E., Brown, A.J., 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells (2006) Kidney Int., 70, pp. 654-659; \n\nKnutson, A., Hellman, P., Akerstrom, G., Westin, G., Characterization of the human Megalin/LRP-2 promoter in vitro and in primary parathyroid cells (1998) DNA. Cell Biol., 17, pp. 551-560; \n\nZisman, A.L., Hristova, M., Ho, L.T., Sprague, S.M., Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease (2007) Am. J. Nephrol., 27, pp. 36-43; \n\nChandra, P., Binongo, J.N., Ziegler, T.R., Schlanger, L.E., Wang, W., Someren, J.T., Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study (2008) Endocr. Pract., 14, pp. 10-17; \n\nCosta, E.M., Feldman, D., Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in rats (1986) Biochem. Biophys. Res. Commun., 137, pp. 742-747; \n\nWiese, R.J., Uhland-Smith, A., Ross, T.K., Prahl, J.M., DeLuca, H.F., Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization (1992) J. Biol. Chem., 267, pp. 20082-20086; \n\nDenda, M., Finch, J., Brown, A.J., Nishii, Y., Kubodera, N., Slatopolsky, E., 1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats (1996) Kidney Int., 50, pp. 34-39; \n\nFukuda, N., Tanaka, H., Tominaga, Y., Fukagawa, M., Kurokawa, K., Seino, Y., Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients (1993) J. Clin. Invest., 92, pp. 1436-1443; \n\nKorkor, A.B., Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure (1987) N. Engl. J. Med., 316, pp. 1573-1577; \n\nMerke, J., Hugel, U., Zlotkowski, A., Szabo, A., Bommer, J., Mall, G., Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia (1987) Kidney Int., 32, pp. 350-353; \n\nBrown, A.J., Dusso, A., Lopez-Hilker, S., Lewis-Finch, J., Grooms, P., Slatopolsky, E., 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs (1989) Kidney Int., 35, pp. 19-23; \n\nKoyama, H., Nishizawa, Y., Inaba, M., Hino, M., Prahl, J.M., DeLuca, H.F., Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure (1994) Am. J. Physiol., 266, pp. F706-F712; \n\nReinhardt, T.A., Horst, R.L., Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo (1990) Endocrinology, 127, pp. 942-948; \n\nPatel, S.R., Ke, H.Q., Hsu, C.H., Regulation of calcitriol receptor and its mRNA in normal and renal failure rats (1994) Kidney Int., 45, pp. 1020-1027; \n\nGoff, J.P., Reinhardt, T.A., Beckman, M.J., Horst, R.L., Contrasting effects of exogenous 1,25-dihydroxyvitamin D [1,25-(OH)2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors (1990) Endocrinology, 126, pp. 1031-1035; \n\nSandgren, M.E., DeLuca, H.F., Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 4312-4314; \n\nUhland-Smith, A., DeLuca, H.F., The necessity for calcium for increased renal vitamin D receptor in response to 1,25-dihydroxyvitamin D (1993) Biochim. Biophys. Acta., 1176, pp. 321-326; \n\nBrown, A.J., Zhong, M., Finch, J., Ritter, C., Slatopolsky, E., The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands (1995) Endocrinology, 136, pp. 1419-1425; \n\nHuang, Y.C., Lee, S., Stolz, R., Gabrielides, C., Pansini-Porta, A., Bruns, M.E., Effect of hormones and development on the expression of the rat 1,25-dihydroxyvitamin D3 receptor gene. Comparison with calbindin gene expression (1989) J. Biol. Chem., 264, pp. 17454-17461; \n\nMartinez, J., Olmos, J.M., de Francisco, A.L., Amado, J.A., Riancho, J.A., Gonzalez-Macias, J., 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with primary and secondary hyperparathyroidism (1994) Bone Miner., 27, pp. 25-32; \n\nDhawan, P., Peng, X., Sutton, A.L., MacDonald, P.N., Croniger, C.M., Trautwein, C., Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase (2005) Mol. Cell Biol., 25, pp. 472-487; \n\nEsteban, L., Vidal, M., Dusso, A., 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation (2004) J. Steroid Biochem. Mol. Biol., pp. 131-137; \n\nArcidiacono, M.V., Sato, T., Alvarez-Hernandez, D., Yang, J., Tokumoto, M., Gonzalez-Suarez, I., EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease (2008) J. Am. Soc. Nephrol., 19, pp. 310-320; \n\nCozzolino, M., Lu, Y., Sato, T., Yang, J., Suarez, I.G., Brancaccio, D., A critical role for enhanced-TGFα and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease (2005) Am. J. Physiol. Renal Physiol., 289, pp. F1096-F1102; \n\nLautrette, A., Li, S., Alili, R., Sunnarborg, S.W., Burtin, M., Lee, D.C., Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach (2005) Nat. Med., 11, pp. 867-874; \n\nMelenhorst, W.B., Visser, L., Timmer, A., Van Den Heuvel, M.C., Stegeman, C.A., van Goor, H., ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? (2009) Am. J. Physiol. Renal Physiol., 297, pp. F781-F790; \n\nMorrison, N.A., Qi, J.C., Tokita, A., Kelly, P.J., Crofts, L., Nguyen, T.V., Prediction of bone density from vitamin D receptor alleles (1994) Nature, 367, pp. 284-287; \n\nKoshiyama, H., Sone, T., Nakao, K., Vitamin-D-receptor-gene polymorphism and bone loss (1995) Lancet, 345, pp. 990-991; \n\nGomez Alonso, C., Naves Diaz, M.L., Diaz-Corte, C., Fernandez Martin, J.L., Cannata Andia, J.B., Vitamin D receptor gene (VDR) polymorphisms: effect on bone mass, bone loss and parathyroid hormone regulation (1998) Nephrol. Dial. Transplant., 13, pp. 73-77; \n\nCarling, T., Kindmark, A., Hellman, P., Lundgren, E., Ljunghall, S., Rastad, J., Vitamin D receptor genotypes in primary hyperparathyroidism (1995) Nat. Med., 1, pp. 1309-1311; \n\nFernandez, E., Fibla, J., Betriu, A., Piulats, J.M., Almirall, J., Montoliu, J., Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure (1997) J. Am. Soc. Nephrol., 8, pp. 1546-1552; \n\nYokoyama, K., Shigematsu, T., Kagami, S., Tsukada, T., Arai, T., Hara, S., Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients (2001) Nephron, 89, pp. 315-320; \n\nKontula, K., Valimaki, S., Kainulainen, K., Viitanen, A.M., Keski-Oja, J., Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol (1997) Br. J. Dermatol., 136, pp. 977-978; \n\nBorras, M., Torregrossa, V., Oliveras, A., Almirall, J., Ma Paz, M., Betriu, A., BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients (2003) J. Nephrol., 16, pp. 116-120; \n\nEisman, J.A., Genetics of osteoporosis (1999) Endocr. Rev., 20, pp. 788-804; \n\nGiannini, S., D'Angelo, A., Nobile, M., Carraro, G., Rigotti, P., Silva-Netto, F., The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation (2002) J. Bone Miner. Res., 17, pp. 1768-1773; \n\nMartin, R.J., McKnight, A.J., Patterson, C.C., Sadlier, D.M., Maxwell, A.P., A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy (2010) Nephrol. Dial. Transplant., 25, pp. 497-503; \n\nStefanic, M., Papic, S., Suver, M., Glavas-Obrovac, L., Karner, I., Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population (2008) Int. J. Immunogenet., 35, pp. 125-131; \n\nvan Driel, M., Koedam, M., Buurman, C.J., Hewison, M., Chiba, H., Uitterlinden, A.G., Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells (2006) FASEB J., 20, pp. 2417-2419; \n\nHammes, A., Andreassen, T.K., Spoelgen, R., Raila, J., Hubner, N., Schulz, H., Role of endocytosis in cellular uptake of sex steroids (2005) Cell, 122, pp. 751-762; \n\nTeramoto, T., Endo, K., Ikeda, K., Kubodera, N., Kinoshita, M., Yamanaka, M., Binding of vitamin D to low-density-lipoprotein (LDL) and LDL receptor-mediated pathway into cells (1995) Biochem. Biophys. Res. Commun., 215, pp. 199-204; \n\nBouillon, R., Okamura, W.H., Norman, A.W., Structure-function relationships in the vitamin D endocrine system (1995) Endocr. Rev., 16, pp. 200-257; \n\nPettifor, J.M., Bikle, D.D., Cavaleros, M., Zachen, D., Kamdar, M.C., Ross, F.P., Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity (1995) Ann. Intern. Med., 122, pp. 511-513; \n\nSawaya, B.P., Koszewski, N.J., Qi, Q., Langub, M.C., Monier-Faugere, M.C., Malluche, H.H., Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure (1997) J. Am. Soc. Nephrol., 8, pp. 271-278; \n\nMacDonald, P.N., Ritter, C., Brown, A.J., Slatopolsky, E., Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathyroid cell culture (1994) J. Clin. Invest., 93, pp. 725-730; \n\nHsu, C.H., Patel, S.R., Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure (1995) Curr. Opin. Nephrol. Hypertens., 4, pp. 302-306; \n\nPatel, S.R., Ke, H.Q., Vanholder, R., Koenig, R.J., Hsu, C.H., Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins (1995) J. Clin. Invest., 96, pp. 50-59; \n\nSela-Brown, A., Russell, J., Koszewski, N.J., Michalak, M., Naveh-Many, T., Silver, J., Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats (1998) Mol. Endocrinol., 12, pp. 1193-1200; \n\nVidal, M., Ramana, C.V., Dusso, A.S., Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription (2002) Mol. Cell Biol., 22, pp. 2777-2787; \n\nJurutka, P.W., Whitfield, G.K., Hsieh, J.C., Thompson, P.D., Haussler, C.A., Haussler, M.R., Molecular nature of the vitamin D receptor and its role in regulation of gene expression (2001) Rev. Endocr. Metab. Disord., 2, pp. 203-216; \n\nRachez, C., Freedman, L.P., Mediator complexes and transcription (2001) Curr. Opin. Cell Biol., 13, pp. 274-280; \n\nRachez, C., Freedman, L.P., Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions (2000) Gene, 246, pp. 9-21; \n\nMay, P., Bock, H.H., Herz, J., Integration of endocytosis and signal transduction by lipoprotein receptors (2003) Sci. STKE, 2003. , PE12; \n\nDunlop, T.W., Vaisanen, S., Frank, C., Carlberg, C., The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha,25(OH)2D3 targets (2004) J. Steroid Biochem. Mol. Biol., pp. 257-260; \n\nTakeyama, K., Masuhiro, Y., Fuse, H., Endoh, H., Murayama, A., Kitanaka, S., Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog (1999) Mol. Cell Biol., 19, pp. 1049-1055; \n\nMizwicki, M.T., Norman, A.W., The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling (2009) Sci. Signal, 2; \n\nOgg, C.S., The intestinal absorption of 47Ca by patients in chronic renal failure (1968) Clin. Sci., 34, pp. 467-471; \n\nRecker, R.R., Saville, P.D., Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables (1971) J. Lab. Clin. Med., 78, pp. 380-388; \n\nWong, R.G., Norman, A.W., Reddy, C.R., Coburn, J.W., Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats (1972) J. Clin. Invest., 51, pp. 1287-1291; \n\nHartenbower, D.L., Coburn, J.W., Reddy, C.R., Norman, A.W., Calciferol metabolism and intestinal calcium transport in the chick with reduced renal function (1974) J. Lab. Clin. Med., 83, pp. 38-45; \n\nLi, Y.C., Amling, M., Pirro, A.E., Priemel, M., Meuse, J., Baron, R., Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice (1998) Endocrinology, 139, pp. 4391-4396; \n\nVan Cromphaut, S.J., Dewerchin, M., Hoenderop, J.G., Stockmans, I., Van Herck, E., Kato, S., Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 13324-13329; \n\nBouillon, R., Van Cromphaut, S., Carmeliet, G., Intestinal calcium absorption: molecular vitamin D mediated mechanisms (2003) J. Cell Biochem., 88, pp. 332-339; \n\nvan Abel, M., Hoenderop, J.G., van der Kemp, A.W., van Leeuwen, J.P., Bindels, R.J., Regulation of the epithelial Ca2+ channels in small intestine as studied by quantitative mRNA detection (2003) Am. J. Physiol. Gastrointest. Liver Physiol., 285, pp. G78-G85; \n\nBrown, A.J., Finch, J., Slatopolsky, E., Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport (2002) J. Lab Clin. Med., 139, pp. 279-284; \n\nAkhter, S., Kutuzova, G.D., Christakos, S., DeLuca, H.F., Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine (2007) Arch. Biochem. Biophys., 460, pp. 227-232; \n\nBenn, B.S., Ajibade, D., Porta, A., Dhawan, P., Hediger, M., Peng, J.B., Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k (2008) Endocrinology, 149, pp. 3196-3205; \n\nFujita, H., Sugimoto, K., Inatomi, S., Maeda, T., Osanai, M., Uchiyama, Y., Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes (2008) Mol. Biol. Cell, 19, pp. 1912-1921; \n\nBrickman, A.S., Coburn, J.W., Norman, A.W., Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man (1972) N. Engl. J. Med., 287, pp. 891-895; \n\nWalling, M.W., Kimberg, D.V., Wasserman, R.H., Feinberg, R.R., Duodenal active transport of calcium and phosphate in vitamin D-deficient rats: effects of nephrectomy, Cestrum diurnum, and 1alpha,25-dihydroxyvitamin D3 (1976) Endocrinology, 98, pp. 1130-1134; \n\nYamamoto, H., Miyamoto, K., Li, B., Taketani, Y., Kitano, M., Inoue, Y., The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine (1999) J. Bone Miner. Res., 14, pp. 240-247; \n\nChanard, J.M., Drueke, T., Zingraff, J., Man, N.K., Russo-Marie, F., Funck-Brentano, J.L., Effects of haemodialysis on fractional intestinal absorption of calcium in uraemia (1976) Eur. J. Clin. Invest., 6, pp. 261-264; \n\nBrown, A.J., Slatopolsky, E., Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (2007) Nat. Clin. Pract. Endocrinol. Metab., 3, pp. 134-144; \n\nSlatopolsky, E., Brown, A., Dusso, A., Role of phosphorus in the pathogenesis of secondary hyperparathyroidism (2001) Am. J. Kidney Dis., 37, pp. S54-S57; \n\nCourbebaisse, M., Thervet, E., Souberbielle, J.C., Zuber, J., Eladari, D., Martinez, F., Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients (2009) Kidney Int., 75, pp. 646-651; \n\nCanalejo, R., Canalejo, A., Martinez-Moreno, J.M., Rodriguez-Ortiz, M.E., Estepa, J.C., Mendoza, F.J., FGF23 fails to inhibit uremic parathyroid glands (2010) J. Am. Soc. Nephrol., 21, pp. 1125-1135; \n\nBrown, A.J., Zhong, M., Finch, J., Ritter, C., McCracken, R., Morrissey, J., Rat calcium-sensing receptor is regulated by vitamin D but not by calcium (1996) Am. J. Physiol., 270, pp. F454-F460; \n\nCanaff, L., Hendy, G.N., Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D (2002) J. Biol. Chem., 277, pp. 30337-30350; \n\nKifor, O., Moore, F.D., Wang, P., Goldstein, M., Vassilev, P., Kifor, I., Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism (1996) J. Clin. Endocrinol. Metab., 81, pp. 1598-1606; \n\nDelmez, J.A., Tindira, C., Grooms, P., Dusso, A., Windus, D.W., Slatopolsky, E., Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium (1989) J. Clin. Invest., 83, pp. 1349-1355; \n\nShiraishi, K., Tsuchida, M., Wada, T., Yoshihiro, S., Takai, K., Suga, A., 22-Oxacalcitriol upregulates p21(WAF1/Cip1) in human parathyroid glands. A preliminary report (2001) Am. J. Nephrol., 21, pp. 507-511; \n\nTeng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J.M., Thadhani, R., Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy (2003) N. Engl. J. Med., 349, pp. 446-456; \n\nNaves-Diaz, M., Alvarez-Hernandez, D., Passlick-Deetjen, J., Guinsburg, A., Marelli, C., Rodriguez-Puyol, D., Oral active vitamin D is associated with improved survival in hemodialysis patients (2008) Kidney Int., 74, pp. 1070-1078; \n\nMartin, K.J., Gonzales, E.A., Gellens, M., Hamm, L.L., Abboud, H., Lindberg, J., 19-Nor-1α,25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis (1998) J. Am. Soc. Nephrol., 9, pp. 1427-1432; \n\nHinkle, C.L., Sunnarborg, S.W., Loiselle, D., Parker, C.E., Stevenson, M., Russell, W.E., Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency (2004) J. Biol. Chem., 279, pp. 24179-24188; \n\nPinkas-Kramarski, R., Alroy, I., Yarden, Y., ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling (1997) J. Mammary Gland Biol. Neoplasia., 2, pp. 97-107; \n\nDusso, A., Arcidiacono, M.V., Yang, J., Tokumoto, M., Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality (2010) J. Steroid Biochem. Mol. Biol., 121 (1-2), pp. 193-198; \n\nChen, C.D., Podvin, S., Gillespie, E., Leeman, S.E., Abraham, C.R., Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 19796-19801; \n\nGalitzer, H., Ben-Dov, I.Z., Silver, J., Naveh-Many, T., Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease (2010) Kidney Int., 77, pp. 211-218; \n\nTominaga, Y., Tsuzuki, T., Uchida, K., Haba, T., Otsuka, S., Ichimori, T., Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma (1999) Kidney Int., 55, pp. 1375-1383; \n\nCordero, J.B., Cozzolino, M., Lu, Y., Vidal, M., Slatopolsky, E., Stahl, P.D., 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor (2002) J. Biol. Chem., 277, pp. 38965-38971; \n\nCozzolino, M., Lu, Y., Finch, J., Slatopolsky, E., Dusso, A.S., P21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium (2001) Kidney Int., 60, pp. 2109-2117; \n\nTokumoto, M., Tsuruya, K., Fukuda, K., Kanai, H., Kuroki, S., Hirakata, H., Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism (2002) Kidney Int., 62, pp. 1196-1207; \n\nLiu, M., Lee, M.H., Cohen, M., Bommakanti, M., Freedman, L.P., Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937 (1996) Genes. Dev., 10, pp. 142-153; \n\nKremer, R., Bolivar, I., Goltzman, D., Hendy, G.N., Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells (1989) Endocrinology, 125, pp. 935-941; \n\nMalluche, H.H., Ritz, E., Lange, H.P., Kutschera, L., Hodgson, M., Seiffert, U., Bone histology in incipient and advanced renal failure (1976) Kidney Int., 9, pp. 355-362; \n\nHruska, K.A., Saab, G., Mathew, S., Lund, R., Renal osteodystrophy, phosphate homeostasis, and vascular calcification (2007) Semin. Dial., 20, pp. 309-315; \n\nXue, Y., Karaplis, A.C., Hendy, G.N., Goltzman, D., Miao, D., Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles (2006) Endocrinology, 147, pp. 4801-4810; \n\nNakane, M., Fey, T.A., Dixon, D.B., Ma, J., Brune, M.E., Li, Y.C., Differential effects of vitamin D analogs on bone formation and resorption (2006) J. Steroid Biochem. Mol. Biol., 98, pp. 72-77; \n\nSlatopolsky, E., Cozzolino, M., Lu, Y., Finch, J., Dusso, A., Staniforth, M., Efficacy of 19-nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia (2003) Kidney Int., 63, pp. 2020-2027; \n\nFriedman, P.A., Gesek, F.A., Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells (1993) Am. J. Physiol., 265, pp. F300-F308; \n\nHoenderop, J.G., Muller, D., Van Der Kemp, A.W., Hartog, A., Suzuki, M., Ishibashi, K., Calcitriol controls the epithelial calcium channel in kidney (2001) J. Am. Soc. Nephrol., 12, pp. 1342-1349; \n\nvan de Graaf, S.F., van der Kemp, A.W., Van Den Berg, D., van Oorschot, M., Hoenderop, J.G., Bindels, R.J., Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5 activity (2006) J. Am. Soc. Nephrol., 17, pp. 26-30; \n\nHoenderop, J.G., Chon, H., Gkika, D., Bluyssen, H.A., Holstege, F.C., St-Arnaud, R., Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice (2004) Kidney Int., 65, pp. 531-539; \n\nEnck, A.H., Berger, U.V., Yu, A.S., Claudin-2 is selectively expressed in proximal nephron in mouse kidney (2001) Am. J. Physiol. Renal Physiol., 281, pp. F966-F974; \n\nBergwitz, C., Roslin, N.M., Tieder, M., Loredo-Osti, J.C., Bastepe, M., Abu-Zahra, H., SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis (2006) Am. J. Hum. Genet., 78, pp. 179-192; \n\nLorenz-Depiereux, B., Benet-Pages, A., Eckstein, G., Tenenbaum-Rakover, Y., Wagenstaller, J., Tiosano, D., Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3 (2006) Am. J. Hum. Genet., 78, pp. 193-201; \n\nSchiavi, S.C., Fibroblast growth factor 23: the making of a hormone (2006) Kidney Int., 69, pp. 425-427; \n\nBachmann, S., Schlichting, U., Geist, B., Mutig, K., Petsch, T., Bacic, D., Kidney-specific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa) (2004) J. Am. Soc. Nephrol., 15, pp. 892-900; \n\nAgarwal, R., Acharya, M., Tian, J., Hippensteel, R.L., Melnick, J.Z., Qiu, P., Antiproteinuric effect of oral paricalcitol in chronic kidney disease (2005) Kidney Int., 68, pp. 2823-2828; \n\nSlatopolsky, E., Brown, A., Dusso, A., Role of phosphorus in the pathogenesis of secondary hyperparathyroidism (2001) Am. J. Kidney Dis., 37, pp. S54-S57; \n\nGiachelli, C.M., Vascular calcification: in vitro evidence for the role of inorganic phosphate (2003) J. Am. Soc. Nephrol., 14, pp. S300-S304; \n\nJerums, G., Panagiotopoulos, S., Tsalamandris, C., Allen, T.J., Gilbert, R.E., Comper, W.D., Why is proteinuria such an important risk factor for progression in clinical trials? (1997) Kidney Int. Suppl., 63, pp. S87-S92; \n\nGekle, M., Renal tubule albumin transport (2005) Annu. Rev. Physiol., 67, pp. 573-594; \n\nGuggino, S.E., Mechanisms of disease: what can mouse models tell us about the molecular processes underlying Dent disease (2007) Nat. Clin. Pract. Nephrol., 3, pp. 449-455; \n\nNorden, A.G., Lapsley, M., Igarashi, T., Kelleher, C.L., Lee, P.J., Matsuyama, T., Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome (2002) J. Am. Soc. Nephrol., 13, pp. 125-133; \n\nDong, X., Craig, T., Xing, N., Bachman, L.A., Paya, C.V., Weih, F., Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function (2003) J. Biol. Chem., 278, pp. 49378-49385; \n\nMacconi, D., Chiabrando, C., Schiarea, S., Aiello, S., Cassis, L., Gagliardini, E., Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides (2009) J. Am. Soc. Nephrol., 20, pp. 123-130; \n\nMathieu, C., Adorini, L., The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents (2002) Trends. Mol. Med., 8, pp. 174-179; \n\nLiu, P.T., Stenger, S., Li, H., Wenzel, L., Tan, B.H., Krutzik, S.R., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response (2006) Science, 311, pp. 1770-1773; \n\nLi, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., Cao, L.P., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system (2002) J. Clin. Invest., 110, pp. 229-238; \n\nLi, Y.C., Qiao, G., Uskokovic, M., Xiang, W., Zheng, W., Kong, J., Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure (2004) J. Steroid Biochem. Mol. Biol., pp. 387-392; \n\nSchwarz, U., Amann, K., Orth, S.R., Simonaviciene, A., Wessels, S., Ritz, E., Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats (1998) Kidney Int., 53, pp. 1696-1705; \n\nKuhlmann, A., Haas, C.S., Gross, M.L., Reulbach, U., Holzinger, M., Schwarz, U., 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat (2004) Am. J. Physiol. Renal Physiol., 286, pp. F526-F533; \n\nHirata, M., Makibayashi, K., Katsumata, K., Kusano, K., Watanabe, T., Fukushima, N., 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats (2002) Nephrol. Dial. Transplant., 17, pp. 2132-2137; \n\nMigliori, M., Giovannini, L., Panichi, V., Filippi, C., Taccola, D., Origlia, N., Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis (2005) Int. J. Immunopathol. Pharmacol., 18, pp. 779-790; \n\nWeinreich, T., Merke, J., Schonermark, M., Reichel, H., Diebold, M., Hansch, G.M., Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells (1991) Am. J. Kidney Dis., 18, pp. 359-366; \n\nZhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A.W., Kong, J., Renoprotective role of the vitamin D receptor in diabetic nephropathy (2008) Kidney Int., 73, pp. 163-171; \n\nProvvedini, D.M., Tsoukas, C.D., Deftos, L.J., Manolagas, S.C., 1,25-Dihydroxyvitamin D3 receptors in human leukocytes (1983) Science, 221, pp. 1181-1183; \n\nVeldman, C.M., Cantorna, M.T., DeLuca, H.F., Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system (2000) Arch. Biochem. Biophys., 374, pp. 334-338; \n\nMizobuchi, M., Morrissey, J., Finch, J.L., Martin, D.R., Liapis, H., Akizawa, T., Combination therapy with an Angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats (2007) J. Am. Soc. Nephrol., 18, pp. 1796-1806; \n\nPanichi, V., Migliori, M., Taccola, D., Filippi, C., De Nisco, L., Giovannini, L., Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats (2001) Kidney Int., 60, pp. 87-95; \n\nMakibayashi, K., Tatematsu, M., Hirata, M., Fukushima, N., Kusano, K., Ohashi, S., A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis (2001) Am. J. Pathol., 158, pp. 1733-1741; \n\nTan, X., Li, Y., Liu, Y., Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy (2006) J. Am. Soc. Nephrol., 17, pp. 3382-3393; \n\nLi, Y., Spataro, B.C., Yang, J., Dai, C., Liu, Y., 1,25-Dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression (2005) Kidney Int., 68, pp. 1500-1510; \n\nRepo, J.M., Rantala, I.S., Honkanen, T.T., Mustonen, J.T., Koobi, P., Tahvanainen, A.M., Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol (2007) Kidney Int., 72, pp. 977-984; \n\nMelenhorst, W.B., Visser, L., Timmer, A., Van Den Heuvel, M.C., Stegeman, C.A., van Goor, H., ADAM17 upregulation in human renal disease: a role in modulating TGF-α availability? (2009) Am. J. Physiol. Renal Physiol., 297, pp. F781-F790; \n\nSantiago-Josefat, B., Esselens, C., Bech-Serra, J.J., Arribas, J., Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors (2007) J. Biol. Chem., 282, pp. 8325-8331; \n\nTerzi, F., Burtin, M., Hekmati, M., Federici, P., Grimber, G., Briand, P., Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury (2000) J. Clin. Invest., 106, pp. 225-234; \n\nHelle, F., Jouzel, C., Chadjichristos, C., Placier, S., Flamant, M., Guerrot, D., Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism (2009) Am. J. Physiol. Renal Physiol., 297, pp. F191-F199; \n\nTsakadze, N.L., Sithu, S.D., Sen, U., English, W.R., Murphy, G., D'Souza, S.E., Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1) (2006) J. Biol. Chem., 281, pp. 3157-3164; \n\nGarton, K.J., Gough, P.J., Philalay, J., Wille, P.T., Blobel, C.P., Whitehead, R.H., Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17) (2003) J. Biol. Chem., 278, pp. 37459-37464; \n\nQian, Y., Li, S., Ye, S., Chen, Y., Zhai, Z., Chen, K., Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats (2008) J. Endocrinol. Invest., 31, pp. 1069-1074; \n\nStinghen, A.E., Goncalves, S.M., Martines, E.G., Nakao, L.S., Riella, M.C., Aita, C.A., Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease (2009) Nephron. Clin. Pract., 111, pp. c117-c126; \n\nvan Ree, R.M., Oterdoom, L.H., de Vries, A.P., Homan van der Heide, J.J., van Son, W.J., Navis, G., Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients (2008) Transplantation, 86, pp. 1713-1719; \n\nAl-Aly, Z., Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy (2008) Transl. Res., 151, pp. 233-239; \n\nMorange, P.E., Tregouet, D.A., Godefroy, T., Saut, N., Bickel, C., Rupprecht, H.J., Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study (2008) J. Mol. Med., 86, pp. 1153-1161; \n\nZhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D., Miao, D., Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice (2008) Kidney Int., 74, pp. 170-179; \n\nMancuso, P., Rahman, A., Hershey, S.D., Dandu, L., Nibbelink, K.A., Simpson, R.U., 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin (2008) J. Cardiovasc. Pharmacol., 51, pp. 559-564; \n\nBodyak, N., Ayus, J.C., Achinger, S., Shivalingappa, V., Ke, Q., Chen, Y.S., Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 16810-16815; \n\nWatson, K.E., Abrolat, M.L., Malone, L.L., Hoeg, J.M., Doherty, T., Detrano, R., Active serum vitamin D levels are inversely correlated with coronary calcification (1997) Circulation, 96, pp. 1755-1760; \n\nPark, C.W., Oh, Y.S., Shin, Y.S., Kim, C.M., Kim, Y.S., Kim, S.Y., Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism (1999) Am. J. Kidney Dis., 33, pp. 73-81; \n\nZittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R., Stehle, P., Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure (2003) J. Am. Coll. Cardiol., 41, pp. 105-112; \n\nWu, J., Garami, M., Cheng, T., Gardner, D.G., 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes (1996) J. Clin. Invest., 97, pp. 1577-1588; \n\nAlborzi, P., Patel, N.A., Peterson, C., Bills, J.E., Bekele, D.M., Bunaye, Z., Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial (2008) Hypertension, 52, pp. 249-255; \n\nMizobuchi, M., Finch, J.L., Martin, D.R., Slatopolsky, E., Differential effects of vitamin D receptor activators on vascular calcification in uremic rats (2007) Kidney Int., 72, pp. 709-715; \n\nHusain, K., Ferder, L., Mizobuchi, M., Finch, J., Slatopolsky, E., Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats (2009) Am. J. Nephrol., 29, pp. 465-472; \n\nMathew, S., Lund, R.J., Chaudhary, L.R., Geurs, T., Hruska, K.A., Vitamin D receptor activators can protect against vascular calcification (2008) J. Am. Soc. Nephrol., 19, pp. 1509-1519; \n\nLondon, G.M., Guerin, A.P., Verbeke, F.H., Pannier, B., Boutouyrie, P., Marchais, S.J., Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency (2007) J. Am. Soc. Nephrol., 18, pp. 613-620; \n\nBarreto, D.V., Barreto, F.C., Liabeuf, S., Temmar, M., Boitte, F., Choukroun, G., Vitamin D affects survival independently of vascular calcification in chronic kidney disease (2009) Clin. J. Am. Soc. Nephrol., 4, pp. 1128-1135; \n\nAihara, K., Azuma, H., Akaike, M., Ikeda, Y., Yamashita, M., Sudo, T., Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice (2004) J. Biol. Chem., 279, pp. 35798-35802; \n\nDoherty, T.M., Tang, W., Dascalos, S., Watson, K.E., Demer, L.L., Shavelle, R.M., Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography (1997) Circulation, 96, pp. 1477-1481; \n\nBrown, A.J., Vitamin D analogs for secondary hyperparathyroidism: what does the future hold? (2007) J. Steroid Biochem. Mol. Biol., 103, pp. 578-583; \n\nTentori, F., Hunt, W.C., Stidley, C.A., Rohrscheib, M.R., Bedrick, E.J., Meyer, K.B., Mortality risk among hemodialysis patients receiving different vitamin D analogs (2006) Kidney Int., 70, pp. 1858-1865; \n\nPalmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., Strippoli, G.F., Vitamin D compounds for people with chronic kidney disease not requiring dialysis (2009) Cochrane Database Syst. Rev., , CD008175; \n\nPalmer, S.C., McGregor, D.O., Craig, J.C., Elder, G., Macaskill, P., Strippoli, G.F., Vitamin D compounds for people with chronic kidney disease requiring dialysis (2009) Cochrane Database Syst. Rev., , CD005633; \n\nArmas, L.A., Hollis, B.W., Heaney, R.P., Vitamin D2 is much less effective than vitamin D3 in humans (2004) J. Clin. Endocrinol. Metab., 89, pp. 5387-5391; \n\nHolick, M.F., Biancuzzo, R.M., Chen, T.C., Klein, E.K., Young, A., Bibuld, D., Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D (2008) J. Clin. Endocrinol. Metab., 93, pp. 677-681; \n\nHeaney, R.P., Armas, L.A., Shary, J.R., Bell, N.H., Binkley, N., Hollis, B.W., 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions (2008) Am. J. Clin. Nutr., 87, pp. 1738-1742; \n\nVieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety (1999) Am. J. Clin. Nutr., 69, pp. 842-856; \n\nHeaney, R.P., Vitamin D: criteria for safety and efficacy (2008) Nutr. Rev., 66, pp. S178-S181; \n\nDusso, A., Lopez-Hilker, S., Rapp, N., Slatopolsky, E., Extra-renal production of calcitriol in chronic renal failure (1988) Kidney Int., 34, pp. 368-375", "hasCitationDuplums" : false, "userChangeableUntil" : "2013-11-14T19:43:02.000+0000", "publishDate" : "2013-11-14T19:42:50.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 2, "ownerInstituteCount" : 14, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 30124428, "link" : "/api/publication/30124428", "label" : "David Feldman. Vitamin D, Vol: 1-2. (2011) ISBN:9780123819789; 9780123819796; 0123819792", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000201, "link" : "/api/subtype/10000201", "label" : "Szakkönyv (Könyv)", "name" : "Szakkönyv", "nameEng" : "Monograph", "docType" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "listPosition" : 337, "published" : true, "oldId" : 10000201, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Vitamin D, Vol: 1-2", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6857995, "link" : "/api/publicationidentifier/6857995", "label" : "ISBN: 9780123819789", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9780123819789", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9780123819789", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 25104598, "link" : "/api/publicationidentifier/25104598", "label" : "ISBN: 9780123819796", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9780123819796", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9780123819796", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 25104599, "link" : "/api/publicationidentifier/25104599", "label" : "ISBN: 0123819792", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "0123819792", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A0123819792", "published" : false, "snippet" : true } ], "publishedAt" : [ { "otype" : "City", "mtid" : 18501, "link" : "/api/city/18501", "label" : "Amsterdam, Hollandia", "partOf" : { "otype" : "Country", "mtid" : 10023, "link" : "/api/country/10023", "label" : "Hollandia", "published" : true, "oldId" : 19, "snippet" : true }, "published" : true, "snippet" : true } ], "pageLength" : 2082, "publishedYear" : 2011, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/23451185", "label" : "Dusso AS et al. Vitamin D and renal disease. (2011) Megjelent: Vitamin D, Vol: 1-2 pp. 1325-1357", "template" : "